FDA Inspection 1174857 — James Benjamin Renfroe MD
The FDA completed an inspection of James Benjamin Renfroe MD on Jul 14, 2022 in Gulf Breeze, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 14, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Gulf Breeze, FL (United States)
Additional details
Clinical Investigator (CI)